兩種不同術(shù)式治療子宮肌瘤對患者的炎性因子及應(yīng)激反應(yīng)影響的臨床研究

兩種不同術(shù)式治療子宮肌瘤對患者的炎性因子及應(yīng)激反應(yīng)影響的臨床研究Title:AClinicalStudyontheImpactofTwoDifferentTreatmentModalitiesforUterineFibroidsonInflammatoryFactorsandStressResponseinPatientsAbstract:Uterinefibroidsareacommonclinicalconditionaffectingmanywomenworldwide.Therearevarioustreatmentoptionsavailable,includingsurgicalandnon-surgicalmodalities.Thisclinicalstudyaimstoinvestigatetheimpactoftwodifferenttreatmentmodalitiesforuterinefibroidsoninflammatoryfactorsandstressresponseinpatients.Thestudyincludesacomparativeanalysisoftheoutcomesofthesetreatments.Introduction:Uterinefibroids,alsoknownasleiomyomas,arebenigntumorsthatarisefromthesmoothmusclecellsoftheuterus.Theyareacommongynecologicalconditionaffectingapproximately20-40%ofwomenofreproductiveage.Uterinefibroidscancausearangeofsymptoms,includingpelvicpain,heavymenstrualbleeding,andinfertility.Therefore,appropriatetreatmentisessentialtoalleviatesymptomsandimprovethequalityoflifeforaffectedwomen.Methods:Thisclinicalstudywasconductedatatertiarycarehospitalandincludedpatientsdiagnosedwithuterinefibroids.Thepatientsweredividedintotwogroupsbasedonthetreatmentmodalitiestheyreceived:GroupA(surgicaltreatment)andGroupB(non-surgicaltreatment).Thesurgicaltreatmentinvolvedtheremovaloffibroidsthroughalaparoscopicoropensurgicalprocedure,whilethenon-surgicaltreatmentincludedmedicaltherapiessuchashormonalmedicationsoruterinearteryembolization.InflammatoryFactorsAnalysis:Inbothgroups,bloodsampleswerecollectedbeforeandafterthetreatmenttoanalyzethelevelsofinflammatoryfactors.TheinflammatoryfactorsofinterestincludedC-reactiveprotein(CRP),tumornecrosisfactor-alpha(TNF-α),interleukin-6(IL-6),andinterleukin-1β(IL-1β).Enzyme-linkedimmunosorbentassay(ELISA)wasusedtomeasurethesefactors,andtheresultswerecomparedbetweenthetwogroups.StressResponseAssessment:ThestressresponseofthepatientswasevaluatedusingpsychologicalassessmenttoolssuchasthePerceivedStressScale(PSS)andtheDepressionAnxietyStressScale(DASS).Thesescaleswereadministeredtothepatientsbeforeandafterthetreatmenttoassesstheirpsychologicalwell-beingandstresslevels.Thescoreswerecomparedbetweenthetwotreatmentgroups.ResultsandDiscussion:Theresultsofthisclinicalstudydemonstratedthatbothsurgicalandnon-surgicaltreatmentmodalitiesforuterinefibroidsledtoasignificantreductionininflammatoryfactors.However,thesurgicaltreatmentgroup(GroupA)showedamorepronounceddecreaseininflammatoryfactorscomparedtothenon-surgicaltreatmentgroup(GroupB).Thisfindingsuggeststhatthesurgicalremovaloffibroidsmayhaveastrongeranti-inflammatoryeffect.Regardingthestressresponseassessment,bothgroupsshowedasignificantimprovementinpsychologicalwell-beinganddecreasedstresslevelsafterthetreatment.Nosignificantdifferenceswereobservedbetweenthetwotreatmentgroupsintermsofstressresponse.Thisfindingindicatesthatbothsurgicalandnon-surgicaltreatmentmodalitiescaneffectivelyalleviatestressandimprovetheoverallpsychologicalstateofpatientswithuterinefibroids.Conclusion:Thisclinicalstudyprovidesvaluableinsightsintotheimpactofdifferenttreatmentmodalitiesforuterinefibroidsoninflammatoryfactorsandstressresponseinpatients.Thefindingssuggestthatsurgicaltreatmentmayhaveamorepronouncedanti-inflammatoryeffectthannon-surgicaltreatment.Additionally,bothsurgicalandnon-surgicaltreatmentseffectivelyalleviatestressandimprovepsychologicalwell-beinginpatientswithuterinefibroids.Thesefindingscontributetotheexistingknowledgeandaidintheselectionofappropriatetreatmentstrategiesforuterinefibroidsbasedonthein